8193681

Source:http://linkedlifedata.com/resource/pubmed/id/8193681

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0005841, umls-concept:C0010174, umls-concept:C0014822, umls-concept:C0086418, umls-concept:C0087111, umls-concept:C0158996, umls-concept:C1879316
pubmed:issue	6
pubmed:dateCreated	1994-6-29
pubmed:abstractText	To evaluate the costs relative to the benefits of using recombinant human erythropoietin (rHuEPO) therapy as an alternative to red blood cell (RBC) transfusions in infants with anemia of prematurity.
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/1-P01 HL46925
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9422751
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Drugs, Investigational, http://linkedlifedata.com/resource/pubmed/chemical/Erythropoietin, http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins
pubmed:status	MEDLINE
pubmed:month	Jun
pubmed:issn	1072-4710
pubmed:author	pubmed-author:HilsenrathP EPE, pubmed-author:MutnickA HAH, pubmed-author:ShiremanT ITI, pubmed-author:StraussR GRG, pubmed-author:WidnessJ AJA
pubmed:issnType	Print
pubmed:volume	148
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	582-8
pubmed:dateRevised	2007-11-14
pubmed:meshHeading	pubmed-meshheading:8193681-Anemia, Neonatal, pubmed-meshheading:8193681-Costs and Cost Analysis, pubmed-meshheading:8193681-Delivery of Health Care, pubmed-meshheading:8193681-Drugs, Investigational, pubmed-meshheading:8193681-Erythrocyte Transfusion, pubmed-meshheading:8193681-Erythropoietin, pubmed-meshheading:8193681-Health Care Costs, pubmed-meshheading:8193681-Humans, pubmed-meshheading:8193681-Infant, Newborn, pubmed-meshheading:8193681-Infant, Premature, Diseases, pubmed-meshheading:8193681-Recombinant Proteins, pubmed-meshheading:8193681-Treatment Outcome
pubmed:year	1994
pubmed:articleTitle	Recombinant human erythropoietin vs transfusions in the treatment of anemia of prematurity. A cost-benefit analysis.
pubmed:affiliation	Social and Administrative Pharmacy Division, School of Pharmacy, University of Wisconsin, Madison.
pubmed:publicationType	Journal Article, Clinical Trial, Comparative Study, Research Support, U.S. Gov't, P.H.S., Multicenter Study